L
Last Price
52 Week Range
NT$18.60 - NT$33.75
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | NT$2.62B |
EV | NT$2.29B |
Shares Outstanding | 80.65M |
Beta | 0.09 |
Industry | Drug Manufacturers - Specialty & Generic |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -4.18% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
L
LIWANLI Innovation Co., Ltd.
3054
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Data Unavailable
Employees
Website
www.liwanli.com.twIPO Date
2002-11-19
Headquarters
No. 258, Liancheng Road, 16th Floor-1, Zhonghe District, New Taipei City 235, Taiwan
The last closing price of LIWANLI Innovation (3054) is NT$32.45, reflecting a +2.04% change from the prior session. Last updated: January 1, 2026 at 12:31 AM Eastern Time
Review the recent 3054 stock performance trends:Past 1 Month: LIWANLI Innovation (3054) shares have +37.21%.Past 3 Months: The stock has +31.38%.Past 6 Months: 3054 shares have +36.34%. Last updated: January 1, 2026 at 12:19 AM Eastern Time
Over the last year, LIWANLI Innovation (3054) has established a 52-week price range between a high of NT$33.75 and a low of NT$18.60. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:19 AM Eastern Time
LIWANLI Innovation (3054) is considered a low volatility stock. It has a beta of 0.09, which means it typically moves 0.09 times as much as the broader market. Over the past 52 weeks, 3054 has traded within a NT$18.60 – NT$33.75 range. Last updated: January 1, 2026 at 12:19 AM Eastern Time
A NT$1,000 investment in LIWANLI Innovation 5 years ago, when the stock was trading around NT$24.00, would be worth approximately NT$1352.17 today, based solely on share price performance (excluding dividends). This represents a total return of 35.22% over the period, equivalent to a compound annual growth rate (CAGR) of 6.22%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:19 AM Eastern Time
The current LIWANLI Innovation (3054) market capitalization is approximately NT$2.62B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, LIWANLI Innovation's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:19 AM Eastern Time
In the most recently reported quarter, LIWANLI Innovation (3054) generated NT$51.45M in revenue, representing a +118.62% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 4:23 AM Eastern Time
In the most recently reported fiscal year, LIWANLI Innovation (3054) generated net income of NT$-32.07M, compared with NT$5.10M in the prior fiscal year, representing a -728.53% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 4:23 AM Eastern Time
According to its latest quarterly filing, LIWANLI Innovation (3054) reported EBITDA of NT$-8.23M, representing a +20.43% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 4:23 AM Eastern Time
Based on the latest available data, LIWANLI Innovation (3054) is currently trading at a last twelve months (LTM) P/E ratio of 52.53x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 4:23 AM Eastern Time
In the most recently reported quarter, LIWANLI Innovation (3054) revenue was NT$51.45M. Earnings per share (EPS) for the quarter were NT$0.66. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 4:23 AM Eastern Time
LIWANLI Innovation (3054) does not currently pay a dividend. Over the last twelve months (LTM), the company paid NT$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 4:23 AM Eastern Time
Based on the latest available analyst coverage, LIWANLI Innovation (3054) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 4:23 AM Eastern Time
Like other publicly traded stocks, LIWANLI Innovation (3054) shares are bought and sold on stock exchanges such as TWSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for LIWANLI Innovation (3054) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 3054 to your watchlist.
LIWANLI Innovation trades under the ticker symbol 3054 on the TWSE stock exchange. The ticker 3054 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
LIWANLI Innovation (3054) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest LIWANLI Innovation (3054) stock peers based on overlapping products, services, and competitive dynamics:Transcend Information (2451)Apacer Technology (8271) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to LIWANLI Innovation.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.